Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
暂无分享,去创建一个
[1] X. Chen,et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells , 2006, Nature Genetics.
[2] R. Bernards,et al. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene , 2005, Nature Cell Biology.
[3] Megan F. Cole,et al. Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.
[4] Kevin Eggan,et al. Nuclear Reprogramming of Somatic Cells After Fusion with Human Embryonic Stem Cells , 2005, Science.
[5] M. Eilers,et al. Transcriptional regulation and transformation by Myc proteins , 2005, Nature Reviews Molecular Cell Biology.
[6] Shinya Yamanaka,et al. Differential Roles for Sox15 and Sox2 in Transcriptional Control in Mouse Embryonic Stem Cells* , 2005, Journal of Biological Chemistry.
[7] F. Miller,et al. Isolation and Characterization of Multipotent Skin‐Derived Precursors from Human Skin , 2005, Stem cells.
[8] S. Dalton,et al. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism , 2005, Development.
[9] Ettore Appella,et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression , 2005, Nature Cell Biology.
[10] Li Zhong,et al. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. , 2005, Blood.
[11] H. Schöler,et al. Nuclei of Embryonic Stem Cells Reprogram Somatic Cells , 2004, Stem cells.
[12] H. Itoh,et al. The Adaptor Protein Nck1 Mediates Endothelin A Receptor-regulated Cell Migration through the Cdc42-dependent c-Jun N-terminal Kinase Pathway* , 2004, Journal of Biological Chemistry.
[13] P. Pasceri,et al. Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[14] P. Dyce,et al. Stem cells with multilineage potential derived from porcine skin. , 2004, Biochemical and biophysical research communications.
[15] S. Cawley,et al. Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAs , 2004, Cell.
[16] P. Greengard,et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.
[17] M. Murakami,et al. The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.
[18] J. Nichols,et al. Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.
[19] S. Yamanaka,et al. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells , 2003, Nature.
[20] B. Lüscher,et al. Stimulation of c‐MYC transcriptional activity and acetylation by recruitment of the cofactor CBP , 2003, EMBO reports.
[21] Andrea Cocito,et al. Genomic targets of the human c-Myc protein. , 2003, Genes & development.
[22] Shinya Yamanaka,et al. Fbx15 Is a Novel Target of Oct3/4 but Is Dispensable for Embryonic Stem Cell Self-Renewal and Mouse Development , 2003, Molecular and Cellular Biology.
[23] R. Lovell-Badge,et al. Multipotent cell lineages in early mouse development depend on SOX2 function. , 2003, Genes & development.
[24] R. Fodde,et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling , 2002, Nature Genetics.
[25] John L Cleveland,et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. , 2002, Genes & development.
[26] Z. Kam,et al. Regulation of S33/S37 phosphorylated β-catenin in normal and transformed cells , 2002 .
[27] Nathalie Perreault,et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. , 2002, Development.
[28] J. Massagué,et al. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. , 2002, Nature.
[29] Z. Kam,et al. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells. , 2002, Journal of cell science.
[30] Norio Nakatsuji,et al. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells , 2001, Current Biology.
[31] A. Sadikot,et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin , 2001, Nature Cell Biology.
[32] Channing S. Mahatan,et al. The Gut-enriched Krüppel-like Factor (Krüppel-like Factor 4) Mediates the Transactivating Effect of p53 on the p21 WAF1/Cip1 Promoter* , 2000, The Journal of Biological Chemistry.
[33] M. Cole,et al. The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals , 2000, Molecular and Cellular Biology.
[34] T. Kitamura,et al. Plat-E: an efficient and stable system for transient packaging of retroviruses , 2000, Gene Therapy.
[35] J. Miyazaki,et al. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.
[36] J. Darnell,et al. Stat3 as an Oncogene , 1999, Cell.
[37] M. Katsuki,et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells , 1999, The EMBO journal.
[38] J. Nichols,et al. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. , 1999, Developmental biology.
[39] Tony Pawson,et al. Mammalian Grb2 Regulates Multiple Steps in Embryonic Development and Malignant Transformation , 1998, Cell.
[40] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[41] H. Schöler,et al. Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 , 1998, Cell.
[42] M. Cole,et al. The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.
[43] J L Cleveland,et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.
[44] A. Smith,et al. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. , 1998, Genes & development.
[45] K. Latham,et al. Expression of myc‐family, myc‐interacting, and myc‐target genes during preimplantation mouse development , 1997, Molecular reproduction and development.
[46] I. Wilmut,et al. "Viable Offspring Derived from Fetal and Adult Mammalian Cells" (1997), by Ian Wilmut et al. , 2014 .
[47] Robert V Farese,et al. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[48] N. Corbi,et al. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. , 1995, Genes & development.
[49] Yamamura Ken-ichi,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .
[50] H. Niwa,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.
[51] G. Martin,et al. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Kaufman,et al. Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.
[53] Z. Kam,et al. Regulation of S 33 / S 37 phosphorylated β-catenin in normal and transformed cells , 2022 .